ADC Therapeutics SA (NYSE:ADCT)
ADC Therapeutics SA
NYSE:ADCT
Gross Margin
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides.
The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Current Gross Margin
ADCT
97.6%
Average Gross Margin
ADCT
64.4%
Industry Gross Margin
Biotechnology
64.9%
Gross Margin History
Statistics
Gross Margin
Gross Margin
| 1 Year | 3 Years | 5 Years | |
|---|---|---|---|
| Average | 77.3% | 64.4% | 64.4% |
| Median | 96.3% | 96.1% | 96.1% |
| Min | 0% | 0% | 0% |
| Max | 97.6% | 97.6% | 97.6% |
History Chart
Gross Margin
Gross Margin
Gross Margin Across Competitors
Gross Margin Comparison
ADC Therapeutics SA Competitors
ADC Therapeutics SA Competitors
| Country | CH |
| Market Cap | 596M USD |
| Gross Margin |
98%
|
| Country | US |
| Market Cap | 268B USD |
| Gross Margin |
70%
|
| Country | US |
| Market Cap | 130B USD |
| Gross Margin |
75%
|
| Country | AU |
| Market Cap | 131B AUD |
| Gross Margin |
55%
|
| Country | US |
| Market Cap | 78.1B USD |
| Gross Margin |
76%
|
| Country | US |
| Market Cap | 70.6B USD |
| Gross Margin |
88%
|
Profitability Report
View the profitability report to see the full profitability analysis for ADC Therapeutics SA.
